miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Christine Esau(Ionis Pharmaceuticals (United States)), Scott Davis(Ionis Pharmaceuticals (United States)), Susan Murray(Ionis Pharmaceuticals (United States)), Xing Yu(Ionis Pharmaceuticals (United States)), Sanjay K. Pandey(Ionis Pharmaceuticals (United States)), Michael Pear(Ionis Pharmaceuticals (United States)), Lynnetta M. Watts(Ionis Pharmaceuticals (United States)), Sheri Booten(Ionis Pharmaceuticals (United States)), Mark J. Graham(Ionis Pharmaceuticals (United States)), Robert A. McKay(Ionis Pharmaceuticals (United States)), Amuthakannan Subramaniam(Ionis Pharmaceuticals (United States)), Stephanie Propp(Ionis Pharmaceuticals (United States)), Bridget Lollo(Ionis Pharmaceuticals (United States)), Susan M. Freier(Ionis Pharmaceuticals (United States)), C. Frank Bennett(Ionis Pharmaceuticals (United States)), Sanjay Bhanot(Ionis Pharmaceuticals (United States)), Brett P. Monia(Ionis Pharmaceuticals (United States))
Cited by 2,059Open Access